Delaware district court permits nanostring's counterclaims that 10x genomics and harvard violated the antitrust laws

Seattle--(business wire)--nanostring technologies, inc. (nasdaq:nstg), a leading provider of life science tools for discovery and translational research, provided comments on yesterday's order of the united states district court for the district of delaware in nanostring's patent litigation with 10x genomics and president and fellows of harvard college. in its order, the court granted nanostring's motion to add new counterclaims for antitrust and unfair competition violations as well as the aff.
NSTG Ratings Summary
NSTG Quant Ranking